β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute Coronary Events‐2)

BACKGROUND: The prognostic impact of β‐blockers (BB) in acute coronary syndrome (ACS) patients without heart failure (HF) or left ventricular dysfunction is controversial, especially in the postreperfusion era. We sought to determine whether a BB therapy before admission for ACS has a favorable in‐h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Am Heart Assoc
Main Authors: Abi Khalil, Charbel, AlHabib, Khalid F., Singh, Rajvir, Asaad, Nidal, Alfaleh, Hussam, Alsheikh‐Ali, Alawi A., Sulaiman, Kadhim, Alshamiri, Mostafa, Alshaer, Fayez, AlMahmeed, Wael, Al Suwaidi, Jassim
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2017
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5779059/
https://ncbi.nlm.nih.gov/pubmed/29263035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007631
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares